SyntheticMR AB (publ)

NGM:SYNT Voorraadrapport

Marktkapitalisatie: SEK 1.2b

SyntheticMR Inkomsten in het verleden

Verleden criteriumcontroles 3/6

SyntheticMR's earnings have been declining at an average annual rate of -6.4%, while the Healthcare Services industry saw earnings growing at 16.1% annually. Revenues have been growing at an average rate of 13.2% per year. SyntheticMR's return on equity is 8.6%, and it has net margins of 10.6%.

Belangrijke informatie

-6.4%

Groei van de winst

-7.2%

Groei van de winst per aandeel

Healthcare Services Groei van de industrie-11.7%
Inkomstengroei13.2%
Rendement op eigen vermogen8.6%
Nettomarge10.6%
Volgende winstupdate21 May 2024

Recente prestatie-updates uit het verleden

Recent updates

Should You Think About Buying SyntheticMR AB (publ) (NGM:SYNT) Now?

Dec 20
Should You Think About Buying SyntheticMR AB (publ) (NGM:SYNT) Now?

What Does SyntheticMR AB (publ)'s (NGM:SYNT) Share Price Indicate?

Sep 21
What Does SyntheticMR AB (publ)'s (NGM:SYNT) Share Price Indicate?

Some Investors May Be Worried About SyntheticMR's (NGM:SYNT) Returns On Capital

Mar 18
Some Investors May Be Worried About SyntheticMR's (NGM:SYNT) Returns On Capital

There Are Reasons To Feel Uneasy About SyntheticMR's (NGM:SYNT) Returns On Capital

Nov 29
There Are Reasons To Feel Uneasy About SyntheticMR's (NGM:SYNT) Returns On Capital

What Does SyntheticMR AB (publ)'s (NGM:SYNT) Share Price Indicate?

Aug 06
What Does SyntheticMR AB (publ)'s (NGM:SYNT) Share Price Indicate?

Why SyntheticMR AB (publ) (NGM:SYNT) Could Be Worth Watching

Feb 23
Why SyntheticMR AB (publ) (NGM:SYNT) Could Be Worth Watching

A Look At The Intrinsic Value Of SyntheticMR AB (publ) (NGM:SYNT)

Jan 27
A Look At The Intrinsic Value Of SyntheticMR AB (publ) (NGM:SYNT)

Should You Think About Buying SyntheticMR AB (publ) (NGM:SYNT) Now?

Nov 10
Should You Think About Buying SyntheticMR AB (publ) (NGM:SYNT) Now?

Read This Before Selling SyntheticMR AB (publ) (NGM:SYNT) Shares

Mar 09
Read This Before Selling SyntheticMR AB (publ) (NGM:SYNT) Shares

What Percentage Of SyntheticMR AB (publ) (NGM:SYNT) Shares Do Insiders Own?

Feb 11
What Percentage Of SyntheticMR AB (publ) (NGM:SYNT) Shares Do Insiders Own?

SyntheticMR AB (publ) (NGM:SYNT) Insiders Increased Their Holdings

Dec 03
SyntheticMR AB (publ) (NGM:SYNT) Insiders Increased Their Holdings

Opbrengsten en kosten

Hoe SyntheticMR geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

NGM:SYNT Opbrengsten, kosten en inkomsten (SEK Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
31 Dec 239410430
30 Sep 23856420
30 Jun 23836400
31 Mar 23807370
31 Dec 22746350
30 Sep 22718330
30 Jun 22657310
31 Mar 22582300
31 Dec 21638300
30 Sep 21608290
30 Jun 21575290
31 Mar 21553290
31 Dec 20521270
30 Sep 2047-6290
30 Jun 2048-3270
31 Mar 20512260
31 Dec 19484240
30 Sep 195312230
30 Jun 195213220
31 Mar 195014200
31 Dec 185115190
30 Sep 184914180
30 Jun 184512170
31 Mar 18398160
31 Dec 17388160
30 Sep 17348150
30 Jun 17307130
31 Mar 17286120
31 Dec 16222120
30 Sep 1615190
30 Jun 1614480
31 Mar 1611190
31 Dec 159090
30 Sep 157-4100
30 Jun 155-9110
31 Mar 155-8100
31 Dec 144-790
30 Sep 145-690
30 Jun 145-580
31 Mar 145-570
31 Dec 134-570
30 Sep 134-460

Kwaliteitswinsten: SYNT has a high level of non-cash earnings.

Groeiende winstmarge: SYNT's current net profit margins (10.6%) are higher than last year (8%).


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: SYNT's earnings have declined by 6.4% per year over the past 5 years.

Versnelling van de groei: SYNT's earnings growth over the past year (70.3%) exceeds its 5-year average (-6.4% per year).

Winst versus industrie: SYNT earnings growth over the past year (70.3%) exceeded the Healthcare Services industry 70.3%.


Rendement op eigen vermogen

Hoge ROE: SYNT's Return on Equity (8.6%) is considered low.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden